HIF1A and endometrial cancer: Nevertheless, several published studies on breast and endometrial cancer using similar or lower dosing and only slightly longer treatment demonstrated an effect of metformin in pre- and post-therapeutic biopsies in immunohistochemistry or RNA microarray [40, 41, 42], although the focus of these studies was not on hypoxia or the HIF1A pathway.